Rick Ryan
InvestorGeneral Partner at Cultivation Capital · General Partner at Cultivation Capital Life Sciences · Board director at Euclises Pharmaceuticals
Missouri
Writes $100K – $3.5M checks · typically $1.8M
Find your path to Rick
176 people in our graph share verified history with Rick — schools, employers, funds. One of them is your warm intro.
Quinn LiunlockedRick: together at Washington University in St. Louis (1992–1994)
Rick: together at Washington University in St. Louis
×9Rick: together at Cultivation Capital
Rick: together at Monsanto
About
Rick Ryan has over 35 years of experience in business management and technology development within the life science industry, holding executive roles at both multinationals and early-stage ventures. He was VP of the Drug Discovery & Development business unit at Millipore until 2010 and previously served as President of LINCO Research and held Director-level positions at Monsanto. He currently serves as CEO of Apertus Pharmaceuticals, and holds a B.S. in Chemistry, a PhD in Biochemistry, and an executive MBA from Washington University in St. Louis.
Contact· self-published, not guessed
Invests in
Biotech
Board director at Euclises Pharmaceuticals
Intro paths
→
In turn, Rick can intro founders to Euclises Pharmaceuticals's investors below.
Euclises Pharmaceuticals's investors · 4
Co-founders at Euclises Pharmaceuticals
RW
Robert W. KarrExecutive Officer, Director
Experience
- Cultivation Capital Life SciencesGeneral Partnercurrent2013 — presentSt. Louis
- The Winfield GroupPresidentcurrent2011 — presentSt. Louis MO
- Apertus PharmaceuticalsExec Chairmancurrent2024 — presentSt. Louis, MO
- Apertus PharmaChief Executive Officer2012 — 2024St, Louis
- MilliporeVice President, Drug Discovery Business Unit2006 — 2010
- Linco ResearchPresident1999 — 2006
- EmbrexVice President, Global Commercial Development1996 — 1998Research Triangle Park, NC
- MonsantoVarious Dir and Mgr level positions1982 — 1996
Skills & more
Chemistry23Life Sciences53ELISA19Drug Discovery85PharmaceuticalsCommercialization70Molecular Biology7Lifesciences48Entrepreneurship8Biotechnology98Immunology9Protein Chemistry3
+12 more
VaccinesTechnology TransferBiomarker DiscoveryValidationBiopharmaceuticalsCross-functional Team LeadershipDrug DevelopmentGLPStrategyLeadershipPharmaceutical IndustryMedicinal ChemistryFrom Rick's professional profile.
Colleagues at Cultivation Capital
Andrew Dearing
General Partner at Cultivation Capital
Andy Cloyd
Principal at Cultivation Capital
Barry Sandweiss
General Partner at Cultivation Capital
Bobby Sandage
General Partner at Cultivation Capital
Brian Matthews
Cofounder & General Partner at Cultivation Capital
Caleb Eidem
General Counsel at Cultivation Capital
Camila Petignat
Partner at The Yield Lab Latam
Catherine Matthes
Venture Advisor at Cultivation Capital
Frequently asked questions
- Who is Rick Ryan?
- Rick Ryan has over 35 years of experience in business management and technology development within the life science industry, holding executive roles at both multinationals and early-stage ventures. He was VP of the Drug Discovery & Development business unit at Millipore until 2010 and previously served as President of LINCO Research and held Director-level positions at Monsanto. He currently serves as CEO of Apertus Pharmaceuticals, and holds a B.S. in Chemistry, a PhD in Biochemistry, and an executive MBA from Washington University in St. Louis.
- Where does Rick Ryan work?
- Rick Ryan is General Partner at Cultivation Capital and Board director at Euclises Pharmaceuticals.
- What does Rick Ryan invest in?
- Rick Ryan invests in Biotech.
- What check size does Rick Ryan write?
- Rick Ryan typically writes checks of $100K – $3.5M.
- Where did Rick Ryan go to school?
- Rick Ryan studied at Washington University in St. Louis (MBA, Business Administration/Marketing); University of Illinois Urbana-Champaign (PhD, Biochemistry); Central College (BS, Chemistry).
Same school
Also attended Washington University in St. Louis348
Lee FixelFounder of AdditionMax WechterSenior Director of AI at Lerer HippeauMark LevinRetired Founding Partner at Third Rock VenturesJess OynickHead of Talent at Union Square Ventures (USV)Andrew ForysiakOwner, AJF and Associates at Riphean InvestmentsDavid GoadSenior Associate, Strategic Investment at Echo Health Ventures
+ 342 more
Also attended University of Illinois Urbana-Champaign864
Max LevchinCo-founder of PayPal; founder, chairman & CEO of Affirm; partner at SciFi VCLuke NosekCo-founder of PayPal; co-founder of GigafundSundeep PeechuGeneral Partner at Felicis VenturesDeep NisharInvestment Team at General CatalystPrashant ShahPartner at Monta Vista CapitalNoorPartner at Clear Ventures
+ 858 more
Also attended Central College6
Mike TudeenInvestor at HLM Investment PartnersKirstie LuehringOffice & Communications Coordinator at ManchesterStory Group, LLCTej DhawanSenior Advisor at Next Level VenturesMARY JOHNSONExecutive Officer at Growers EdgeTodd SutphenExecutive Officer at Makusafe_Todd VerdoornExecutive Officer at DiaMedica Therapeutics
Shared employers
Also worked at Millipore8
Paul HungInvestor at Endurance28Michael JohnsonPresident at NJII Venture StudioNola MastersonVenture Fund Partner at PortfoliaSteven FitzsimmonsFounder at FreshpaintErik SchaeferExecutive Officer at AssayQuant TechnologiesPhilip LeeExecutive Officer at Senti Biosciences
+ 2 more
Also worked at Monsanto76
Andrew AbramsPartner at NSVMartha SchlicherGeneral Partner at Cultivation CapitalGanesh KishoreInvestor at Spruce Capital PartnersNick RosaInvestor at Sandbox IndustriesChas EggertOperating Partner at iSelect FundJohn HamerManaging Partner, DCVC Bio at DCVC (Data Collective)
+ 70 more